Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ERK
    (2)
  • Endogenous Metabolite
    (2)
  • HCV Protease
    (2)
  • Apoptosis
    (1)
  • MEK
    (1)
  • PAK
    (1)
  • SARS-CoV
    (1)
  • VEGFR
    (1)
  • Others
    (8)
Filter
Search Result
Results for "

h 77

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    13
    TargetMol | All_Pathways
  • Natural Products
    1
    TargetMol | Natural_Products
  • Antibody Products
    6
    TargetMol | Antibody_Products
H 77
H-77, H77
T2548182131-82-6
H 77 is a new effective renin inhibitor. H 77 is angiotensinogen (6-13)-octapeptide in which the peptide bond -CO-NH- at the Leu(9)-Leu(11) linkage is replaced by a -CH2-NH- bond.
  • Inquiry Price
Inquiry
Size
QTY
JTK-853
T15631954389-09-4
JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase, exhibiting effective antiviral activity in HCV replicon cells with EC50s of 0.38 μM for genotype 1a H77 strain and 0.035 μM for genotype 1b Con1 strain.
  • $4,859
8-10 weeks
Size
QTY
AH 7725
AH-7725, AH7725
T2367133459-28-8
AH 7725 is an inhibitor of the asthma attack.
  • $1,520
6-8 weeks
Size
QTY
SCH772984
T6066942183-80-4
SCH772984 is an ERK inhibitor that inhibits ERK1 and ERK2 (IC50=4/1 nM) and is highly selective and ATP-competitive. SCH772984 exhibits antitumor activity against BRAF or RAS mutant cells.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
LCH-7749944
GNF-PF-2356
T11826796888-12-5
LCH-7749944 (GNF-PF-2356) is a potent PAK4 inhibitor with an IC50 of 14.93 μM, effectively suppressing the proliferation of human gastric cancer cells by downregulating the PAK4/c-Src/EGFR/cyclin D1 pathway and inducing apoptosis.
  • $45
In Stock
Size
QTY
SCH772984 HCl
T23337
SCH772984 HCl is a selective inhibitor of ERK1/2 that displays behaviors of both type I and type II kinase inhibitors, with IC50s of 4 and 1 nM, respectively. SCH772984 HCl has nanomolar cellular potency in tumor cells with mutations in BRAF, NRAS, or KRA
  • $95
Inquiry
Size
QTY
BFH772
BFH-722
T3599890128-81-1
BFH772, a structure analogue of BAW2881, is a potent and selective VEGF inhibitor. BFH772 is highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM. BFH772 inhibits the ligand induced autophosphorylation of RET, PDGFR, and KIT kinases, wit
  • $38
In Stock
Size
QTY
Asunaprevir
BMS-650032
T4474630420-16-5
Asunaprevir (BMS-650032) is an effective hepatitis C virus (HCV) NS3 protease inhibitor.
  • $44
In Stock
Size
QTY
Metoprolol acid
SL 77-010, H117-04, H 117/04, Atenolol acid
T2115556392-14-4
Metoprolol acid is a urinary metoprolol metabolite and doesn't work pharmacologically.
  • $282
7-10 days
Size
QTY
21-Deoxycortisol
T36915641-77-0
21-Deoxycortisol is a corticosteroid metabolite of 17-hydroxyprogesterone produced in the adrenal glandvia11-hydroxylation by 11β-hydroxylase.1,2Serum levels of 21-deoxycortisol are elevated in patients with congenital adrenal hyperplasia that are heterozygous for mutations inCYP2A21, the gene encoding steroid 21-hydroxylase, and have been used as a biomarker for the detection of 21-hydroxylase deficiencies. 1.Fiet, J., Villette, J.-M., Galons, H., et al.The application of a new highly-sensitive radioimmunoassay for plasma 21-deoxycortisol to the detection of steroid-21-hydroxylase deficiencyAnn. Clin. Biochem.31(Pt. 1)56-64(1994) 2.Cristoni, S., Cuccato, D., Sciannamblo, M., et al.Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoringRapid Commun. Mass Spectrom.18(1)77-82(2004)
    Inquiry
    TG11-77 HCl
    T696082490544-34-6
    TG11-77 HCl is a novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist. TG11-77 HCl has a Schild KB of 9.7 nM on EP2, a water solubility of 2.5 mM, a brain-to-plasma ratio of 0.4, and a plasma half-life of 2.4 h in mice. TG11-77 HCl are representative second generation EP2 antagonists with improved pharmacodynamic and pharmacokinetic properties.
    • $1,520
    6-8 weeks
    Size
    QTY
    TG11-77 free base
    T696092490544-33-5
    TG11-77 free base is a novel, Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist. TG11-77 free base has a Schild KB of 9.7 nM on EP2, a water solubility of 2.5 mM, a brain-to-plasma ratio of 0.4, and a plasma half-life of 2.4 h in mice. TG11-77 free base are representative second generation EP2 antagonists with improved pharmacodynamic and pharmacokinetic properties.
    • $1,520
    6-8 weeks
    Size
    QTY